Statistical analysis of the SARS-CoV-2 effect on the gestation and childbirth course

  • Received 10.01.2022

  • Revised 09.03.2022

  • Accepted 29.03.2022



  • 1,032 Views

  • Retrieved from Vol. 4, No. 1, 2022

  • Pages 131-135

Summary. Pregnancy is known to increase the risk of obstetric and neonatal sequelae in many viral complications. COVID-19, according to the WHO, is a disease caused by SARS-CoV-2 infection. Coronavirus disease in 2019, caused by severe acute respiratory syndrome, has spread rapidly around the world and has become a pandemic. Today, data on the impact of this disease on pregnancy and the development of possible complications for the fetus are being actively studied.  The aim of the study – to learn the effect of SARS-CoV-2 in pregnant women on the subsequent gestation and childbirth course; to conduct a comparative analysis of the incidence of these complications with the overall average for the Perinatal Center "MUNICIPAL NON-PROFIT ENTERPRISE "TERNOPIL MUNICIPAL CITY HOSPITAL No. 2". Materials and Methods. The archived medical records including pregnancy and childbirth record form No. 096/o were analyzed in 33 parturient women, who labored in the Perinatal Center "MUNICIPAL NON-PROFIT ENTERPRISE "TERNOPIL MUNICIPAL CITY HOSPITAL No.2" in 2021–2022 and had SARS-CoV-2 coronavirus during this pregnancy. The incidence of pregnancy and childbirth complications in this group was analyzed in comparison with the overall average for this maternity hospital in 2021. The overall average for the Perinatal Center "MUNICIPAL NON-PROFIT ENTERPRISE "TERNOPIL MUNICIPAL CITY HOSPITAL No.2" for 2021 was calculated for 2218 childbirths that took place during this period. Results. The results showed that there was an increase in the incidence of pregnancy and childbirth complications in parturient women who had SARS-CoV-2 coronavirus during pregnancy compared with the average group. Thus, in the study group of women after coronavirus disease, the incidence of pregnancy complications was (compared to the average): placental dysfunction – 75.7 % (33.6 %), gestational toxicosis development – 51.5 % (24.3 %), abnormal amniotic fluid volume – 27.2 % (18.5 %), urinary tract infections – 15.1 %  (8.8 %). The incidence of childbirth complications in the group of women who had SARS-CoV-2 coronavirus also increased significantly. Thus, in this group of women the number of physiological childbirths was 45 % (with an average of 51 %), the number of cesarean sections was 36.3 %  (with an average of 25.2 %), dystocia and abnormal labors occurred in 18 % of women (with an average of 4.4 %), vacuum extraction was used in 6 % of women (with 2.2 % in the average group). The number of premature babies (15 %) and low birth-weight babies (21.2 %) increased among newborns in the group of women who had SARS-CoV-2 coronavirus. Conclusions. As a result of the analysis it was found that parturient women after SARS-CoV-2 had a significantly higher incidence of pregnancy and childbirth complications compared with the average. Timely prevention and diagnosis of complications after SARS-CoV-2 allows to treat effectively and perform on time delivery in this group of women and has positive consequences for both women and newborns

pregnancy, SARS-CoV-2-coronavirus, pregnancy and childbirth complications, premature childbirth, low birth-weight

https://doi.org/10.11603/bmbr.2706-6290.2022.1.12981

[1] Racicot  K.  Risks  associated  with  viral  infections during  pregnancy.J  Ciin  Invest.2017;127(5): 1591-9.DOI: 10.1172/JCS87490.

[2] Huang С, Wang Y, Ls X.Cisnscal futures of patients infected  with  2019  novel  coronavirus  in  Wuhan,  China. Lancet. 2020;24: 45-51.

[3] Kostyuk OO., Shunko ЕЕ. [Mother and child in a giobal pandemic of coronavirus infection (New Challenges for the health  care  system)].  Ukrainsky  zhurnal  perinatolohiia  i pediatria. 2020;2: 17-26. Ukrainian.

[4] Jianhua  Chi,  Wenjian  Gong,  Qinglei  Gao. Clinical characteristics  and  outcomes  of  pregnant  women  with COVID-19  andrisk  of  vertical  transmission:  a  systematic review. Arch GynecolObstet. 2021;303(2): 337-45.

[5] Wastnedge  EAN,  Reynolds  RM,  van  Boeckel  SR. Pregnancy and COVID-19. Physiol Rev. 2021;101: 303-18.

[6] Rasmussen  SA,  Smulian  JS, Lednicky  JA.  MPH Coronavirus  Disease  2019  (COVID-19)  and  pregnancy: what  obstetrians  need  to  know.  American  Journal  of Obstetrics and Genecology. 2020;222(5): 415-26.

[7] Dehan Liu, Lin Li, Xin Wu. Pregnancy and Perinatal Outcomes of Women with Coronavirus Disease (covid-19) Pneumonia: a preliminary analysis. AJR. 2020;215: 127-32.

[8] Schjenken  JE,  Tolosa  JM,  Paul  JW.  Mechanisms of  maternal  immune  tolerance  during  pregnancy,  recent advances in research on the human placenta. Available   from:   https://www.intechopen.com/books/recent-advances-in-researchon-the-human-placenta/mechanisms-of-maternal-immunetolerance-during-pregnancy.

[9] Nile  SH,  Nile А,  QiuJ.  COVID-19:  pathogenesis, cytokine  storm  and  therapeutic  potential  of  interferons. Cytokine Growth Factor Rev. 2020;53: 66-70.

[10] Veenstra  van  Nieuwenhoven  AL,  Heineman  MJ,Faas MM. Тhe immunology of successful pregnancy. Hum Reprod Update. 2003;9: 347-57.

[11] Yang M, Yang L, Wang X. Decline of plasmacytoid dendritic cells and their subsets in normal pregnancy are related with hormones. J Reprod Med. 2015;60: 423-9.

[12] Siiteri  PK,  Febres  F,  Clemens  LE.  Progesterone and  maintenance  of  pregnancy:  is  progesterone  nature’s immunosuppressant? Ann N Y Acad Sci 286, 1 Biochemical A. 1997; 25: 384-97.

[13] Ji H-L, Zhao R, Matalon S, Matthay MA. Elevated plasmin(ogen)  as  a  common  risk  factor  for  COVID-19 susceptibility. Physiol Rev.2020;100: 1065-75.

[14] Burton  GJ,  Fowden AL,  Thornburg  KL.  Placental origins of chronic disease. Physiol Rev. 2016;96: 1509-65.

[15] Mol  BWJ,  Roberts  CT,  Thangaratinam  S. Pre-eclampsia. Lancet. 2016; 387: 999-1011.

[16] Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366: l2381.

[17] Baergen  RN,  Heller  DS.  Placental  pathology  in Covid-19  positive  mothers:  preliminary  findings.  Pediatr Dev Pathol. 2020;23: 177-80.

[18] Dong  L,  Tian  J,  He  S,  et  al.  Possible  vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020;323: 1846-848.

[19] Rabi FA, Al Zoubi MS, Kasasbeh GA.SARS-CoV-2 and  coronavirus  disease  2019:  what  we  know  so  far. Pathogens. 2020;9: 231.

[20] Shkolnyk  OS,  Shlemkevych AM,  Malanchuk  OM, Sharhorodska EB, Hakobian HR. [Influence of SARS-CoV-2 on  pregnancy  and  fetus.  VISNYK  Ukr  med  stomat  akad. 2021;2(74): 208-13. Ukrainian. 

[21] Riabokon  OV,  Cherkasky  VV,  Riabokon  YuYu. [Coronavirus disease in pregnant women: the current state of the issue]. Infekts khvor. 2021;1(103): 45-52. Ukrainian.